Aligos Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALGS and other ETFs, options, and stocks.About ALGS
Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of therapeutics for chronic liver diseases and viral infections. The firm is focused on the discovery and development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses, as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH).
ALGS Key Statistics
Stock Snapshot
With a market cap of 49.32M, Aligos Therapeutics(ALGS) trades at $7.97. The stock has a price-to-earnings ratio of -0.93.
On 2026-04-03, Aligos Therapeutics(ALGS) stock moved within a range of $7.23 to $8.00. With shares now at $7.97, the stock is trading +10.2% above its intraday low and -0.4% below the session's peak.
Trading activity shows a volume of 39.48K, compared to an average daily volume of 47.02K.
Over the past 52 weeks, Aligos Therapeutics(ALGS) stock has traded between a high of $13.69 and a low of $3.76.
Over the past 52 weeks, Aligos Therapeutics(ALGS) stock has traded between a high of $13.69 and a low of $3.76.
Analyst ratings
100%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.